<DOC>
	<DOCNO>NCT02579720</DOCNO>
	<brief_summary>The purpose non interventional study ( NIS ) observe efficacy Pollinex® Quattro short-term revaccination patient already successfully desensitize least five year ago grass-pollen develop recurrent allergy .</brief_summary>
	<brief_title>Revaccination With Pollinex® Quattro</brief_title>
	<detailed_description>The increase prevalence allergy represent major problem health care system . Approximately 500 million people suffer worldwide allergic rhinitis ( AR ) . Allergic rhinitis Type 1 hypersensitive disorder , initiate IgE antibody . Whereas seasonal allergic rhinitis ( SAR ) cause different allergen find outdoors grass , tree weed pollen , perennial allergic rhinitis ( PAR ) cause allergen mainly find indoors dust mite , mould animal hair . Specific immunotherapy ( SIT ) presently constitute causal therapy available common practice . SIT indicate case IgE-mediated allergic disease include two form treatment option : subcutaneous ( SCIT ) sublingual immunotherapy ( SLIT ) . Both therapy aim train immune system react suppose pathological allergen , instead develop tolerance . Even though allergy vaccination applied century , commonly use SCIT require 90 injection three five year . Pollinex® Quattro currently ultra-short term medicinal product require four preseasonal injection . The immunological effect associate Pollinex® Quattro show increase allergen-specific IgG antibody decrease allergen-specific IgE antibody well shift Th2 Th1 type-immune reaction . Previous study therapeutic efficacy Pollinex® Quattro come positive conclusion regard tolerability decrease allergic symptom . As ultra-short course SCIT , Pollinex® Quattro might decrease number noncompliance withdrawal revaccination patient already undergone intensive immunisation therapy . In non-interventional study , patient treat Pollinex® Quattro patient decide use anti-allergic drug treatment grass pollen allergy compare due allergic symptoms grass pollen season May July . For purpose , rhinoconjunctivitis asthmatic symptom well use concomitant medication document dia</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adults child age 12 year , diagnose recurrent seasonal allergic rhinitis ( SAR ) cause grass pollen . A previous specific immunotherapy finish least five year ago successful . Contraindications accord patient information leaflet</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Recurrent Grass Pollen Allergy</keyword>
	<keyword>Pollinex® Quattro</keyword>
</DOC>